Wigal Sharon B
AVIDA Inc., Newport Beach, CA, United States.
Front Psychol. 2019 Aug 21;10:1796. doi: 10.3389/fpsyg.2019.01796. eCollection 2019.
The time of onset and the duration of treatment effect are important considerations in the choice of the medication to be prescribed in treating children, adolescents, and adults with ADHD. Early onset of effect may facilitate preparation for school, improved behavior during the trip to school, and attention during morning classes. Sustained treatment effect through afternoon and evening hours can be important because impairments associated with ADHD are not limited to the naturalistic classroom. Laboratory school protocols (LSPs) provide a simulated, rigorously controlled classroom setting environment and have proven valuable for providing pharmacokinetic and pharmacodynamic information about medications, and other treatments used in managing ADHD in school-aged children and across the lifespan.
This paper is an invited mini-review of LSPs of stimulant medication, which includes data from multiple, randomized, double-blind, and placebo-controlled medication trials for ADHD. Assessment endpoints included the permanent product measure of performance (PERMP), Swanson, Kotkin, Agler, M-Flynn, and Pelham (SKAMP) rating scale in the preschool assessment laboratory (PAL), child/adolescent, and adult workplace environment (AWE) studies. These measures allow the study of improvement in attention and behavior in individuals with ADHD.
Analog classroom settings (LSP or AWE) have been used to assess immediate and modified-release stimulant formulations of medications to treat ADHD in multiple age groups. Results based on both subjective (e.g., SKAMP ratings) and objective (e.g., PERMP) measures are used as clinical outcomes in testing drugs currently in development for ADHD.
The LSP and its extension to PAL and AWE settings continue to be used to assess the time-course of effect of ADHD medications because they provide valuable information in their respective structured, controlled environments.
在为患有注意力缺陷多动障碍(ADHD)的儿童、青少年和成人开处方时,药物起效时间和治疗效果持续时间是选择药物的重要考虑因素。早期起效可能有助于为上学做准备,改善上学途中的行为以及上午课程中的注意力。整个下午和晚上都能持续产生治疗效果很重要,因为与ADHD相关的功能损害并不局限于自然环境中的课堂。实验室学校方案(LSPs)提供了一个模拟的、严格控制的课堂环境,并且已被证明对于提供有关药物以及用于治疗学龄儿童和各年龄段ADHD的其他治疗方法的药代动力学和药效学信息很有价值。
本文是一篇关于兴奋剂药物实验室学校方案的特邀小型综述,其中包括来自多项针对ADHD的随机、双盲和安慰剂对照药物试验的数据。评估终点包括在学前评估实验室(PAL)、儿童/青少年和成人工作场所环境(AWE)研究中的永久产品绩效测量(PERMP)、斯旺森、科特金、阿格勒、M - 弗林和佩勒姆(SKAMP)评定量表。这些测量方法有助于研究ADHD患者注意力和行为的改善情况。
模拟课堂环境(LSP或AWE)已被用于评估多种年龄组中治疗ADHD的药物的速释和缓释剂型。基于主观(如SKAMP评分)和客观(如PERMP)测量的结果被用作测试目前正在研发的ADHD药物的临床结果。
LSP及其在PAL和AWE环境中的扩展继续被用于评估ADHD药物的疗效时间过程,因为它们在各自结构化、可控的环境中提供了有价值的信息。